Real life application of basophil activation test: A real challenge for diagnosis and treatment monitoring of atopy-related diseases?

F. Garziano, M. Bocchino, E.M. Borriello, A. Stanziola, C. La Rocca, F. Carbone, F. Flavio, A. Sanduzzi, F. Perna (Naples, Italy)

Source: Annual Congress 2012 - Aspects of clinical asthma
Session: Aspects of clinical asthma
Session type: Thematic Poster Session
Number: 2390
Disease area: Airway diseases

Congress or journal article abstractE-poster

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
F. Garziano, M. Bocchino, E.M. Borriello, A. Stanziola, C. La Rocca, F. Carbone, F. Flavio, A. Sanduzzi, F. Perna (Naples, Italy). Real life application of basophil activation test: A real challenge for diagnosis and treatment monitoring of atopy-related diseases?. Eur Respir J 2012; 40: Suppl. 56, 2390

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Real life experience with omalizumab and mepolizumab in severe asthma : do patient baseline features preclude effectiveness comparison ?
Source: International Congress 2019 – Real-world experience of monoclonal antibodies in asthma
Year: 2019


Does timeliness of diagnosis influence survival and treatment response in idiopathic pulmonary fibrosis?  Real- world results from the EMPIRE registry.
Source: International Congress 2017 – Idiopathic pulmonary fibrosis: from the bench to the bedside
Year: 2017

Real life study showing the epidemiological profile and adherence to treatment of patients with severe allergic asthma in use of omalizumab in the past year.
Source: International Congress 2018 – Biomarkers for evaluating asthma
Year: 2018


Capability of classical diagnostic procedure in relation with specific inhalation challenge for conclusive diagnosis in allergic asthma
Source: Annual Congress 2008 - Asthma and inhalation injuries at work
Year: 2008

Real prevalence of severe asthma in developing countries – Is the diagnosis correct?
Source: Virtual Congress 2020 – Clinical parameters in severe asthma
Year: 2020


Real current situation of management and for patient with asthma at community
Source: Annual Congress 2012 - Diagnostic insights and decision making in primary care
Year: 2012

Air travel in chronic lung disease: can clinical variables predict response to the hypoxic challenge test?
Source: Virtual Congress 2021 – Hypoxia, exercise and respiratory function in pathophysiological conditions
Year: 2021


Conversion of tuberculosis screening tests during biological therapy in patients with rheumatic diseases: what’s beyond screening values?
Source: International Congress 2018 – Tuberculosis transmission and screening strategies
Year: 2018



Do laboratory challenge tests for occupational asthma represent what happens in the workplace?
Source: Eur Respir J, 51 (6) 1800059; 10.1183/13993003.00059-2018
Year: 2018



Effectiveness evaluation of anti-IgE treatment at 3rd year: Real life Turkey data
Source: International Congress 2016 – Asthma points to ponder
Year: 2016


Sputum induction for assessment of biomarkers in early development of new drugs for respiratory disease in a proof of concept setting
Source: International Congress 2016 – Airway biomarkers
Year: 2016


Control of asthma in real life: still a valuable goal?
Source: Eur Respir Rev 2015; 24: 361-369
Year: 2015



Discrepancy of non-invasive inflammatory markers and lung function tests to current level of clinical control in childhood asthma
Source: Annual Congress 2009 - FeNO and other biomarkers in childhood asthma
Year: 2009

Do measures of bronchial responsiveness add information in diagnosis and monitoring of patients with asthma?
Source: Eur Respir J 2001; 18: 439-441
Year: 2001


LATE-BREAKING ABSTRACT: Real life impact of long acting beta-2-agonist withdrawal in controlled step 3 asthma patients
Source: International Congress 2016 – Novel strategies on COPD and asthma management
Year: 2016



Clinical asthma phenotypes in the real world: opportunities and challenges
Source: Breathe 2015; 11:186-193
Year: 2015



Blood eosinophilia in patients with COPD, a real life evaluation
Source: International Congress 2018 – Biomarkers of COPD and asthma-COPD overlap syndrome (ACOS)
Year: 2018




Patients with asthma and comorbid allergic rhinitis: Is optimal quality of life achievable in real life?
Source: Annual Congress 2011 - Asthma: risk factors and comorbidities
Year: 2011


Real world residual disease manifestations after 2-years anti-IL-5 treatment for severe asthma
Source: Virtual Congress 2020 – Severe asthma phenotypes and outcomes
Year: 2020




Do we need new asthma control tests?
Source: Eur Respir J 2014; 44: 1116-1118
Year: 2014